塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/03/11 | 7,159 | 7,159 | 6,973 | 7,011 | -223 | -3.1% | 2,253,400 |
2022/03/10 | 7,167 | 7,265 | 7,122 | 7,234 | +125 | +1.8% | 2,394,000 |
2022/03/09 | 7,212 | 7,241 | 6,977 | 7,109 | -68 | -0.9% | 2,612,800 |
2022/03/08 | 7,781 | 7,817 | 7,152 | 7,177 | -671 | -8.5% | 4,097,500 |
2022/03/07 | 7,800 | 8,019 | 7,782 | 7,848 | +133 | +1.7% | 3,058,700 |
2022/03/04 | 7,835 | 7,840 | 7,601 | 7,715 | -84 | -1.1% | 1,893,200 |
2022/03/03 | 7,800 | 7,831 | 7,755 | 7,799 | +22 | +0.3% | 1,315,300 |
2022/03/02 | 7,714 | 7,777 | 7,682 | 7,777 | -16 | -0.2% | 1,256,800 |
2022/03/01 | 7,735 | 7,829 | 7,720 | 7,793 | +152 | +2% | 2,074,200 |
2022/02/28 | 7,599 | 7,646 | 7,434 | 7,641 | +28 | +0.4% | 2,908,500 |
2022/02/25 | 7,483 | 7,840 | 7,405 | 7,613 | +130 | +1.7% | 5,754,900 |
2022/02/24 | 7,390 | 7,502 | 7,365 | 7,483 | +45 | +0.6% | 1,509,500 |
2022/02/22 | 7,501 | 7,543 | 7,366 | 7,438 | -147 | -1.9% | 1,456,700 |
2022/02/21 | 7,531 | 7,650 | 7,351 | 7,585 | -96 | -1.2% | 1,127,600 |
2022/02/18 | 7,543 | 7,722 | 7,526 | 7,681 | +47 | +0.6% | 1,392,400 |
2022/02/17 | 7,615 | 7,669 | 7,551 | 7,634 | -11 | -0.1% | 1,292,500 |
2022/02/16 | 7,695 | 7,729 | 7,583 | 7,645 | +42 | +0.6% | 1,837,300 |
2022/02/15 | 7,765 | 7,798 | 7,580 | 7,603 | -166 | -2.1% | 1,986,600 |
2022/02/14 | 7,720 | 7,828 | 7,638 | 7,769 | -98 | -1.2% | 1,923,100 |
2022/02/10 | 7,829 | 7,920 | 7,759 | 7,867 | ±0 | ±0% | 2,159,400 |
2022/02/09 | 7,620 | 7,893 | 7,603 | 7,867 | +3 | ±0% | 3,739,100 |
2022/02/08 | 8,209 | 8,350 | 7,834 | 7,864 | -120 | -1.5% | 7,797,000 |
2022/02/07 | 7,919 | 8,039 | 7,858 | 7,984 | +230 | +3% | 3,624,800 |
2022/02/04 | 7,900 | 8,029 | 7,567 | 7,754 | -170 | -2.1% | 5,268,800 |
2022/02/03 | 7,411 | 8,000 | 7,409 | 7,924 | +363 | +4.8% | 5,227,200 |
2022/02/02 | 7,152 | 7,720 | 7,117 | 7,561 | +470 | +6.6% | 6,642,000 |
2022/02/01 | 7,177 | 7,177 | 6,837 | 7,091 | +664 | +10.3% | 4,968,500 |
2022/01/31 | 6,428 | 6,464 | 6,325 | 6,427 | +112 | +1.8% | 1,616,600 |
2022/01/28 | 6,290 | 6,390 | 6,195 | 6,315 | +165 | +2.7% | 2,052,000 |
2022/01/27 | 6,453 | 6,453 | 6,119 | 6,150 | -247 | -3.9% | 2,817,800 |
2022/01/26 | 6,666 | 6,683 | 6,333 | 6,397 | -392 | -5.8% | 3,129,000 |
2022/01/25 | 6,915 | 6,960 | 6,746 | 6,789 | -121 | -1.8% | 1,621,100 |
2022/01/24 | 6,856 | 6,912 | 6,727 | 6,910 | -31 | -0.4% | 1,707,000 |
2022/01/21 | 7,020 | 7,063 | 6,880 | 6,941 | -59 | -0.8% | 2,250,600 |
2022/01/20 | 7,023 | 7,114 | 6,931 | 7,000 | -118 | -1.7% | 1,801,600 |
2022/01/19 | 7,279 | 7,289 | 7,085 | 7,118 | -270 | -3.7% | 1,888,400 |
2022/01/18 | 7,525 | 7,553 | 7,375 | 7,388 | -92 | -1.2% | 1,206,700 |
2022/01/17 | 7,528 | 7,605 | 7,477 | 7,480 | -9 | -0.1% | 787,000 |
2022/01/14 | 7,545 | 7,586 | 7,418 | 7,489 | -106 | -1.4% | 1,385,800 |
2022/01/13 | 7,576 | 7,619 | 7,513 | 7,595 | +42 | +0.6% | 1,026,700 |
2022/01/12 | 7,603 | 7,655 | 7,541 | 7,553 | -24 | -0.3% | 1,315,100 |
2022/01/11 | 7,616 | 7,720 | 7,520 | 7,577 | -83 | -1.1% | 1,283,900 |
2022/01/07 | 7,733 | 7,784 | 7,617 | 7,660 | -50 | -0.6% | 1,349,000 |
2022/01/06 | 7,711 | 7,938 | 7,670 | 7,710 | +66 | +0.9% | 2,626,200 |
2022/01/05 | 8,198 | 8,224 | 7,295 | 7,644 | -588 | -7.1% | 5,649,100 |
2022/01/04 | 8,109 | 8,234 | 8,107 | 8,232 | +107 | +1.3% | 909,500 |
2021/12/30 | 8,113 | 8,190 | 8,101 | 8,125 | +3 | ±0% | 982,700 |
2021/12/29 | 8,140 | 8,189 | 8,025 | 8,122 | -89 | -1.1% | 1,055,800 |
2021/12/28 | 8,200 | 8,233 | 8,143 | 8,211 | +50 | +0.6% | 808,000 |
2021/12/27 | 8,183 | 8,225 | 8,126 | 8,161 | -40 | -0.5% | 767,200 |
851~
900
件表示中 / 3773件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 255,000円 | +20.9% | +10.6% | 2.59% | 12.06倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 776,600円 | +2.2% | +28.0% | 1.80% | 12.43倍 | 1.51倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 162,000円 | +0.9% | +380.2% | 4.81% | 22.32倍 | 1.92倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
協和キリン | 254,500円 | -3.5% | -11.3% | 2.36% | 23.37倍 | 1.58倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
エーザイ | 453,800円 | +0.1% | -3.4% | 3.53% | 30.85倍 | 1.52倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム